World

Oxford University, AstraZeneca begin advanced trials of coronavirus vaccine

As part of the procedure, the trial will expand the age range of testing to children from 5 to 12 years old and adu

Published May 22, 2020 Updated May 22, 2020 09:38am

2 min

Comments

By Fahad Zulfikar

Add BRecorder as a trusted
source on Google

As part of the procedure, the trial will expand the age range of testing to children from 5 to 12 years old and adults 56 and older.
Adults will be randomly chosen to receive one or two doses of an already licensed vaccine against meningococcus for comparison.
AstraZeneca has agreed to initially supply at least 400 million doses of the vaccine and secured total manufacturing capacity to produce 1 billion doses.

As part of the procedure, the trial will expand the age range of testing to children from 5 to 12 years old and adults 56 and older. The other, larger stage will test the vaccine’s effectiveness in volunteers 18 and older.

https://twitter.com/business/status/1263750966429523969

Recently, AstraZeneca received funding worth 1.2 billion dollars from United States for its efforts to get the immunization tested and ready for use.

Adults will be randomly chosen to receive one or two doses of an already licensed vaccine against meningococcus for comparison.

The volunteers will be recruited across the United Kingdom and will record their reactions in an e-diary and attend some follow-up visits. Some will be given swabs for taking samples at home.

The British-Swedish drugmaker has agreed to initially supply at least 400 million doses of the vaccine and secured total manufacturing capacity to produce 1 billion doses, with first deliveries in September. AstraZeneca’s development program of the vaccine includes a phase three clinical trial with 30,000 participants and a pediatric trial.

Read Comments